Table 2.
Suggested initial evaluation of prognostic factors in a patient with AML (adapted from 10,17 )
IHC indicates immunohistochemistry; PCR, polymerase chain reaction; APL, acute promyelocytic leukemia; UPD, uniparental disomy.
*Not recommended in all guidelines.10
